Mayne Pharma Group Limited

May 22, 2020

Mayne Pharma launches BAC 300 capsules in the United States

Apr 16, 2020

Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA

Oct 02, 2019

Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US

May 22, 2019

FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis

Apr 30, 2019

FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%

Feb 13, 2019

Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States

Jan 30, 2019

TOLSURA (TM) (SUBA®-itraconazole) Antifungal Capsule Now Available in the United States

Dec 17, 2018

HedgePath Pharmaceuticals and Mayne Pharma Enter into Updated Collaboration and Funding Agreements

Dec 11, 2018

Mayne Pharma receives FDA approval of Tolsura(TM) (SUBA®-itraconazole capsules) for the treatment of certain fungal infections

Nov 12, 2018

Metrics Contract Services Announces Serialization Capabilities at Greenville Site

Oct 26, 2018

Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio